These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 6173074)

  • 21. Serum protease inhibitors promote anchorage-independent growth of transformed cells in serum-free medium.
    Chen JK
    Life Sci; 1992; 51(5):375-80. PubMed ID: 1378169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural inhibitors of the coagulation system.
    Messmore HL
    Semin Thromb Hemost; 1982 Oct; 8(4):267-75. PubMed ID: 6184781
    [No Abstract]   [Full Text] [Related]  

  • 23. Reactivity of a hereditary abnormal antithrombin III fraction in the inhibition of thrombin and factor Xa.
    Tran TH; Bondeli C; Marbet GA; Duckert F
    Thromb Haemost; 1980 Oct; 44(2):92-5. PubMed ID: 7455997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determination of functional activity of alpha 1-protease inhibitor and alpha 2-macroglobulin in human plasma using elastase.
    Gaillard MC; Kilroe-Smith TA
    J Clin Chem Clin Biochem; 1987 Mar; 25(3):167-72. PubMed ID: 2439646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proceedings: The relationship between antithrombin III, progressive antithrombin activity and anti Xa activity in plasma.
    Whigham K; Howie PW; Forbes CD; Prentice CR
    Thromb Diath Haemorrh; 1975 Sep; 34(1):365. PubMed ID: 52904
    [No Abstract]   [Full Text] [Related]  

  • 26. Assessment of the relative contribution of different protease inhibitors to the inhibition of plasmin in vivo.
    Levi M; Roem D; Kamp AM; de Boer JP; Hack CE; ten Cate JW
    Thromb Haemost; 1993 Feb; 69(2):141-6. PubMed ID: 7681223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heparin modulation of the fibrinolytic activity of plasmin, miniplasmin and neutrophil leukocyte elastase in the presence of plasma protease inhibitors.
    Kolev K; Komorowicz E; Machovich R
    Blood Coagul Fibrinolysis; 1994 Dec; 5(6):905-11. PubMed ID: 7534486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of the immune response by plasma protease inhibitors. I. Alpha 2-macroglobulin and alpha 1-antitrypsin inhibit natural killing and antibody-dependent cell-mediated cytotoxicity.
    Ades EW; Hinson A; Chapuis-Cellier C; Arnaud P
    Scand J Immunol; 1982 Jan; 15(1):109-13. PubMed ID: 6176014
    [No Abstract]   [Full Text] [Related]  

  • 29. Natural proteinase inhibitors: blood coagulation inhibition and evolutionary relationships.
    Bikfalvi A; Beress L
    Comp Biochem Physiol B; 1987; 87(3):435-41. PubMed ID: 2441925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antifactor Xa activity measured with amidolytic methods.
    Odegård OR; Lie M; Abildgaard U
    Haemostasis; 1976; 5(5):265-75. PubMed ID: 1017722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction between human pancreatic elastase and plasma protease inhibitors.
    Gustavsson EL; Ohlsson K; Olsson AS
    Hoppe Seylers Z Physiol Chem; 1980; 361(2):169-76. PubMed ID: 6153632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The inhibition of the anticoagulant activity of heparin by platelets, brain phospholipids, and tissue factor.
    Ofosu FA; Cerskus AL; Hirsh J; Smith LM; Modi GJ; Blajchman MA
    Br J Haematol; 1984 Jun; 57(2):229-38. PubMed ID: 6733045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inactivation of factor XIa by plasma protease inhibitors: predominant role of alpha 1-protease inhibitor and protective effect of high molecular weight kininogen.
    Scott CF; Schapira M; James HL; Cohen AB; Colman RW
    J Clin Invest; 1982 Apr; 69(4):844-52. PubMed ID: 7076850
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The anti-heparin properties of human low-density lipoprotein.
    MacGregor IR; Lane DA; Kakkar VV
    Biochim Biophys Acta; 1980 Mar; 617(3):472-9. PubMed ID: 7189413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The acceleration of the inhibition of platelet prothrombinase complex by heparin.
    Ellis V; Scully MF; Kakkar VV
    Biochem J; 1986 Jan; 233(1):161-5. PubMed ID: 3954724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Covalent complexes between low molecular weight heparin fragments and antithrombin III - inhibition kinetics and turnover parameters.
    Hoylaerts M; Holmer E; de Mol M; Collen D
    Thromb Haemost; 1983 Apr; 49(2):109-15. PubMed ID: 6868006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Respective roles of antithrombin III and alpha 2 macroglobulin in thrombin inactivation.
    Fischer AM; Tapon-Bretaudiere J; Bros A; Josso F
    Thromb Haemost; 1981 Feb; 45(1):51-4. PubMed ID: 6166063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alpha-1-antitrypsin-Pittsburgh. A potent inhibitor of human plasma factor XIa, kallikrein, and factor XIIf.
    Scott CF; Carrell RW; Glaser CB; Kueppers F; Lewis JH; Colman RW
    J Clin Invest; 1986 Feb; 77(2):631-4. PubMed ID: 3484755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of phosphatidylserine on the inhibition of human factor Xa by the plasma proteinase inhibitors.
    Friedberg RC; Pizzo SV
    Thromb Res; 1988 Jun; 50(6):901-6. PubMed ID: 3261898
    [No Abstract]   [Full Text] [Related]  

  • 40. The behavior of antithrombin III, alpha 2 macroglobulin, and alpha 1 antitrypsin during cardiopulmonary bypass.
    Pickering NJ; Brody JI; Fink GB; Finnegan JO; Ablaza S
    Am J Clin Pathol; 1983 Oct; 80(4):459-64. PubMed ID: 6194683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.